| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/19/2002 | DE10112768A1 New heterocyclic-substituted phenyl compounds, are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, restenosis or tumor diseases |
| 09/19/2002 | DE10111842A1 Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel Antithrombotic carboxamides, their preparation and their use as medicaments |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2473156A1 Rxr activating molecules |
| 09/19/2002 | CA2441454A1 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions |
| 09/19/2002 | CA2441174A1 Novel anti-adhesive compounds and uses thereof |
| 09/19/2002 | CA2441088A1 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 09/19/2002 | CA2440773A1 Novel mhc molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of mhc molecules |
| 09/19/2002 | CA2440618A1 Immunoglobulin superfamily proteins |
| 09/19/2002 | CA2440284A1 Ph-dependent nmda receptor antagonists |
| 09/19/2002 | CA2439637A1 Human serpin polypeptides |
| 09/19/2002 | CA2439498A1 Somatostatin antagonists |
| 09/19/2002 | CA2439231A1 Antithrombotic carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 09/19/2002 | CA2438164A1 Use of preparations containing selenite or selenate |
| 09/19/2002 | CA2437958A1 Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors |
| 09/18/2002 | WO2001070678A2 Substituted biphenyl derivatives |
| 09/18/2002 | EP1241258A2 Stem cell factor |
| 09/18/2002 | EP1240902A1 Carbonyl stress-ameliorating agents |
| 09/18/2002 | EP1240901A1 Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation |
| 09/18/2002 | EP1240900A1 Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy |
| 09/18/2002 | EP1240335A2 Proteases |
| 09/18/2002 | EP1240313A2 Homologues of human heparanase and splice variants thereof |
| 09/18/2002 | EP1240202A2 Inhibitors of complement activation, their preparation and use |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1240166A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240165A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240160A1 Substituted pyridazines having cytokine inhibitory activity |
| 09/18/2002 | EP1239884A2 Methods for preparing pharmaceutical formulations |
| 09/18/2002 | EP1239873A2 Method for localized administration of fibrinolytic metalloproteinases |
| 09/18/2002 | EP1239854A1 Use of a hypoglycemic agent for treating impaired glucose metabolism |
| 09/18/2002 | EP1117633B1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 09/18/2002 | EP0975573B1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
| 09/18/2002 | EP0944386B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 09/18/2002 | EP0917528B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/18/2002 | EP0904285B1 Cyclic adhesion inhibitors |
| 09/18/2002 | EP0904260B1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids |
| 09/18/2002 | EP0840604B1 Non-beta-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof |
| 09/18/2002 | CN1370165A Bispidine compounds useful in treatment of cardiac arrhythmias |
| 09/18/2002 | CN1370147A Novel integrin alpha V\ beta3 inhibitors |
| 09/18/2002 | CN1370146A Alpha/Beta integrin inhibitors |
| 09/18/2002 | CN1370143A Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 09/18/2002 | CN1369561A Cell factor CK-HA and its variant with hematogenesis promoting and immunoregulating functions |
| 09/18/2002 | CN1369507A Process for separating megakaryocyte stimulating factor from human plasma and purifying it and its application |
| 09/18/2002 | CN1369274A 'Zaizhang Kangfu' pill for treating alplastic anemia |
| 09/18/2002 | CN1090963C Fast-acting nemostatic pellet |
| 09/18/2002 | CN1090949C Tongmai shulou vessel-freeing injection and its preparing tech |
| 09/18/2002 | CA2403500A1 Substituted biphenyl derivatives |
| 09/17/2002 | US6451976 Bi-or multifunctional molecules based on a dendroaspin scaffold |
| 09/17/2002 | US6451838 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/17/2002 | US6451831 Treatment with hydantoin derivative |
| 09/17/2002 | US6451810 Amide substituted imidazoquinolines |
| 09/17/2002 | US6451804 Heteroalkylamino-substituted bicyclic nitrogen heterocycles |
| 09/17/2002 | US6451801 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 09/17/2002 | US6451794 2,3-Diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2(COX-2) inhibitors |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451783 Administering to an obese patient or a patient at risk of becoming obese therapeutically effective amount of compound that attenuates binding of agouti-related protein to melanocortin receptors |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451286 Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/16/2002 | CA2376131A1 A method for the production of pharmaceutically active recombinant urokinase |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070681A1 Protein c variants |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070594A2 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070556A1 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 09/12/2002 | WO2002070548A2 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/12/2002 | WO2002070534A1 C2, 8-disubstituted adenosine derivatives and their different uses |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070510A2 Amino dicarboxylic acid derivatives with pharmaceutical properties |
| 09/12/2002 | WO2002070507A2 Glycorticoid receptor antagonists for treatment of diabetes |
| 09/12/2002 | WO2002070504A1 Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent expulsion |
| 09/12/2002 | WO2002070502A1 Dimeric isoflavones |
| 09/12/2002 | WO2002070500A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 09/12/2002 | WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | WO2002070462A1 Substituted amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070461A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/12/2002 | WO2002070459A1 Novel amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070023A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 09/12/2002 | WO2002070001A2 Use of lp82 to treat hematopoietic disorders |
| 09/12/2002 | WO2002070000A1 Recombinant gelatin-like proteins for use as plasma expanders |
| 09/12/2002 | WO2002069999A1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 09/12/2002 | WO2002069988A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 09/12/2002 | WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/12/2002 | WO2002069965A1 Benzimidazole derivatives as therapeutic agents |
| 09/12/2002 | WO2002069960A2 Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock |
| 09/12/2002 | WO2002069899A2 Methods and compositions for the treatment and prevention of smooth muscle cell proliferation |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |